28
Participants
Start Date
August 31, 2015
Primary Completion Date
August 31, 2018
Study Completion Date
September 30, 2018
Diben 1.5 kcal HP
Continuous (24h) application according to a standardized enteral feeding protocol via nasogastric tube or percutaneous endoscopic gastrostomy (PEG); pump-assisted application (Charriére (CH) \> 8), duration according to patient's tolerance and requirements for a maximum of 5 days. Dosage: 21 - 24 kcal/kg body weight/day (corresponding to 14 to 16 ml/kg body weight/day).
Fresubin HP Energy Fibre (1.5 kcal)
Continuous (24h) application according to a standardized enteral feeding protocol via nasogastric tube or percutaneous endoscopic gastrostomy (PEG); pump-assisted application (Charriére (CH) \> 8), duration according to patient's tolerance and requirements for a maximum of 5 days. Dosage: 21 - 24 kcal/kg body weight/day (corresponding to 14 to 16 ml/kg body weight/day).
Universitätsklinikum Innsbruck, Innsbruck
Lead Sponsor
OE Clinical Trial Center (KKS) Universität Innsbruck
UNKNOWN
International Medical Research - Partner GmbH
OTHER
dsh statistical services GmbH
UNKNOWN
Fresenius Kabi
INDUSTRY